Yehuda Ringel Selected Research

Yehuda Ringel Research Topics

9	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2016 - 12/2010
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 05/2012
5	Constipation 08/2013 - 01/2006
4	Diarrhea 08/2013 - 12/2010
3	Inflammation (Inflammations) 01/2021 - 05/2012
3	Abdominal Pain (Pain, Abdominal) 08/2013 - 01/2011
2	Ulcerative Colitis 01/2021 - 05/2012
2	Infections 01/2020 - 05/2012
2	Pain (Aches) 01/2019 - 03/2016
1	Rheumatoid Arthritis 01/2020
1	COVID-19 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019
1	Hypersensitivity (Allergy) 08/2013
1	Weight Loss (Weight Reduction) 05/2012
1	Obesity 05/2012
1	Fecal Incontinence 10/2009
1	Ataxia (Dyssynergia) 04/2007
1	Communicable Diseases (Infectious Diseases) 09/2006
1	Neoplasms (Cancer) 09/2006
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 09/2006
1	Colorectal Neoplasms (Colorectal Cancer) 09/2005
1	Ulcer 07/2005

4	PrebioticsIBA 01/2021 - 09/2005
3	Phenobarbital (Luminal)FDA Link 08/2013 - 12/2010
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2019
1	Dronabinol (THC)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Viral RNAIBA 01/2020
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020
1	Medical MarijuanaIBA 11/2019
1	C-Reactive ProteinIBA 03/2016
1	Plant ExtractsIBA 02/2014
1	Cysteine Proteases (Cysteine Protease)IBA 08/2013
1	OccludinIBA 08/2013
1	Serine Proteases (Serine Protease)IBA 08/2013
1	AntibodiesIBA 01/2012
1	Rifaximin (L 105)FDA Link 01/2011
1	Lubiprostone FDA Link 01/2008
1	Diazepam (Valium)FDA LinkGeneric 04/2007
1	Generic DrugsIBA 09/2006

3	Therapeutics 01/2020 - 07/2005
2	Ambulatory Care (Outpatient Care) 11/2012 - 09/2006
2	Aftercare (After-Treatment) 01/2011 - 04/2007
2	Psychology Biofeedback (Biofeedback) 10/2009 - 04/2007
1	Diet Therapy (Therapy, Diet) 01/2019
1	Neurofeedback 04/2007
1	Colectomy 01/2006